Despite many potential benefits of metformin to target aging-related ailments— and despite a recommendation from the American Diabetes Association that it be tried before any other drug for newly diagnosed Type 2 diabetics — a recent study found that only about half of all such people get metformin as their first prescribed medication. Niteesh Choudhry, associate professor of medicine at Brigham and Women's Hospital, led the study.
News & Research
